Active	Status	Sponsor type	Region	Phase	Filter
5 Active 1 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Krause, Stefan
TRIANGLE, NCT02858258: ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma May 2019 - Dec 2023 : Regulatory submission in EU for front line maintenance MCL	Recruiting	3	870	Europe	R-CHOP/R-DHAP, rituximab, CHOP, DHAP, Ibrutinib (Induction), Imbruvica, ASCT conditioning, THAM or BEAM, Ibrutinib (Maintenance)	Prof. Dr. M. Dreyling (co-chairman), LMU Klinikum	Mantle Cell Lymphoma	05/21	05/26
DaunoDouble, NCT02140242 / 2013-003191-12: Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML	Completed	3	721	Europe, RoW	study part 1 - dose daunorubicin, induction cycles	Technische Universität Dresden, University Hospital Dresden, Masaryk University	Leukemia, Myelocytic, Acute	04/22	04/22
VINCENT, NCT05904106 / 2021-003248-26: Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML	Recruiting	2	146	Europe	Venetoclax plus Azacitidine, standard of care chemotherapy plus gemtuzumab ozogamicin	Technische Universität Dresden, University Hospital Heidelberg, AbbVie	Acute Myeloid Leukemia	09/28	09/28
NCT03188874: Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)	Recruiting	N/A	15000	Europe		Technische Universität Dresden	Acute Myeloid Leukemia (AML)	09/30	09/30
Rösler, Wolf
NCT04291261: Extracorporal Photopheresis with UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease	Completed	2	24	Europe	Uvadex	Universitätsklinikum Hamburg-Eppendorf, Therakos, University Medical Center Regensburg, Arbeitskreis Klinische Forschung PD Dr. med. Seiler GmbH	Acute-graft-versus-host Disease	06/24	06/24